Spok Holdings, Inc.

NASDAQ:SPOK

Medical - Healthcare Information Services

Healthcare
$10.93 +1.60%

+$0.17 today

Market cap
$228.30M
Beta
0.44
P/E (TTM)
17.2
EPS (TTM)
$0.61
Dividend yield
11.93%
52W Low $9.95High $19.31

Volume 0.18M

Average 0.17M

SPOK Interest Expense

Cost of servicing the company's debt during the period.

Spok Holdings, Inc.NASDAQ: SPOK

Interest Expense · Q1 FY2026 · quarter ended Mar 2026

Interest expense remains negative

Q1 FY2026 interest expense was $0, compared with $0 a year earlier. Trailing-twelve-month interest expense was $0.

Context

  • Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Interest Expense vs competitors

How SPOK compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Interest expense amounts to 0.0% of revenue for SPOK, versus a peer median of 3.7%.
SPOK Competitors
Interest Expense for SPOK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CGCCanopy Growth CorporationLTM Mar 2026CA$40.92M CAD-45.1%-32.9%13.1%
DHDefinitive Healthcare Corp.LTM Mar 2026$11.48M USD-14.6%+0.3%4.8%
CERSCerus CorporationLTM Mar 2026$8.11M USD-7.4%+12.7%3.6%
TBRGTruBridge, Inc.LTM Mar 2026$6.3M USD-59.3%+24.9%1.8%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$5.56M USD+379.5%+92.4%6.9%
NRCNational Research CorporationLTM Mar 2026$5.12M USD+77.2%+57.9%3.7%
SENSSenseonics Holdings, Inc.LTM Mar 2026$4.71M USD-39.7%-35.8%11.6%
VMDViemed Healthcare, Inc.LTM Mar 2026$1.31M USD+62.5%+81.7%0.5%
SPOKSpok Holdings, Inc.LTM Mar 2026$0 USD——0.0%
MASS908 Devices Inc.LTM Mar 2026$0 USD——0.0%
SLPSimulations Plus, Inc.LTM Feb 2026$0 USD——0.0%
Peer median (excluding SPOK) —-11.0%+18.8%3.7%

Competitors are the stored peer set for SPOK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue142.15M134.53M139.03M137.65M139.71M
Cost of Revenue72.27M59.25M57.16M28.43M29.57M
Gross Profit69.89M75.28M81.87M109.22M110.14M
Gross Margin49.2%56.0%58.9%79.3%78.8%
Research & Development17.92M13.63M10.55M11.55M12.09M
Selling, General & Admin64.02M54.09M49.52M49.15M50.87M
Operating Expenses81.94M67.72M60.07M90.26M90.43M
Depreciation & Amortization10.45M3.57M4.5M4.15M3.43M
EBITDA(16.89M)4.57M26.82M24.22M24.87M
EBITDA Margin-11.9%3.4%19.3%17.6%17.8%
Operating Income(12.06M)7.57M21.8M18.97M19.71M
Operating Margin-8.5%5.6%15.7%13.8%14.1%
Interest Income320K592K1.1M1.15M820K
Interest Expense00000
Other Income / Expenses(15.28M)(6.57M)524K1.07M1.73M
Income Before Tax(27.33M)997K22.33M20.03M21.44M
Pre-Tax Margin-19.2%0.7%16.1%14.6%15.3%
Income Tax Expense(5.15M)(20.86M)6.66M5.07M5.56M
Net Income(22.18M)21.86M15.67M14.97M15.88M
Net Margin-15.6%16.2%11.3%10.9%11.4%
EPS (Basic)(1.14)1.110.790.740.77
EPS (Diluted)(1.14)1.090.770.730.75
Weighted Avg Shares19.4M19.67M19.95M20.24M20.61M
Weighted Avg Shares (Diluted)19.4M19.99M20.34M20.57M21.07M

Spok Holdings, Inc.

NASDAQ:SPOK

Intrinsic Alpha fair value

Locked

Current Price

$10.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.